Cargando…
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
BACKGROUND: There is a need for novel fluid biomarkers tracking neuroinflammatory responses in Alzheimer’s disease (AD). Our recent cerebrospinal fluid (CSF) proteomics study revealed that migration inhibitory factor (MIF) and soluble triggering receptor expressed on myeloid cells 1 (sTREM1) increas...
Autores principales: | Hok-A-Hin, Yanaika S., del Campo, Marta, Boiten, Walter A., Stoops, Erik, Vanhooren, Melanie, Lemstra, Afina W., van der Flier, Wiesje M., Teunissen, Charlotte E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163795/ https://www.ncbi.nlm.nih.gov/pubmed/37147668 http://dx.doi.org/10.1186/s12974-023-02796-9 |
Ejemplares similares
-
sTREM-1 is a specific biomarker of TREM-1 pathway activation
por: Jolly, Lucie, et al.
Publicado: (2021) -
CSF sTREM2: marking the tipping point between preclinical AD and dementia?
por: Schindler, Suzanne E, et al.
Publicado: (2016) -
Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
por: Ma, Ling-Zhi, et al.
Publicado: (2020) -
The sTREM2 Concentrations in the Blood: A Marker of Neurodegeneration?
por: Ferri, Evelyn, et al.
Publicado: (2021) -
CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study
por: Dong, Ming-Hao, et al.
Publicado: (2022)